Infant formula products developed specifically for babies with certain disorders are “often the best, and sometimes the only option,” Japanese dairy giant Meiji has claimed.
Heinz has installed “advanced” barcode readers at a British infant formula plant to ensure the premium products it manufactures for Chinese consumers aren’t confused with the standard powder destined for the Czech Republic.
Chinese infant formula manufacturer Biostime has made amendments to the contracts it holds with distributors to delete terms that guarantee fixed prices and price floors that may violate Chinese anti-trust laws.
In the midst of an investigation into the pricing practices employed by it and other infant formula manufacturers in China, Biostime has admitted that the terms of its agreements with distributors “may” have broken anti-trust laws.